Anixa Biosciences Inc (ANIX)
2.85
-0.06
(-2.06%)
USD |
NASDAQ |
May 17, 16:00
2.86
+0.01
(+0.35%)
Pre-Market: 20:00
Anixa Biosciences 1 Year Total Returns (Daily): -16.91% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -16.91% |
May 16, 2024 | -13.91% |
May 15, 2024 | -15.07% |
May 14, 2024 | -12.09% |
May 13, 2024 | -12.39% |
May 10, 2024 | -20.84% |
May 09, 2024 | -27.34% |
May 08, 2024 | -23.93% |
May 07, 2024 | -25.58% |
May 06, 2024 | -22.76% |
May 03, 2024 | -23.83% |
May 02, 2024 | -24.04% |
May 01, 2024 | -22.75% |
April 30, 2024 | -27.21% |
April 29, 2024 | -25.98% |
April 26, 2024 | -24.00% |
April 25, 2024 | -35.50% |
April 24, 2024 | -35.10% |
April 23, 2024 | -38.10% |
April 22, 2024 | -39.31% |
April 19, 2024 | -36.59% |
April 18, 2024 | -32.61% |
April 17, 2024 | -32.37% |
April 16, 2024 | -46.90% |
April 15, 2024 | -47.07% |
Date | Value |
---|---|
April 12, 2024 | -41.67% |
April 11, 2024 | -34.29% |
April 10, 2024 | -32.63% |
April 09, 2024 | -26.97% |
April 08, 2024 | -28.76% |
April 05, 2024 | -25.67% |
April 04, 2024 | -28.31% |
April 03, 2024 | -30.21% |
April 02, 2024 | -25.58% |
April 01, 2024 | -22.09% |
March 28, 2024 | -31.28% |
March 27, 2024 | -30.24% |
March 26, 2024 | -28.21% |
March 25, 2024 | -25.92% |
March 22, 2024 | -12.41% |
March 21, 2024 | -8.89% |
March 20, 2024 | -5.57% |
March 19, 2024 | -11.76% |
March 18, 2024 | -13.97% |
March 15, 2024 | -11.72% |
March 14, 2024 | -28.87% |
March 13, 2024 | -23.92% |
March 12, 2024 | -25.96% |
March 11, 2024 | -22.36% |
March 08, 2024 | -34.21% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-70.07%
Minimum
Mar 27 2020
290.5%
Maximum
Mar 18 2021
7.93%
Average
-4.83%
Median
Dec 09 2019
1 Year Total Returns (Daily) Benchmarks
CEL-SCI Corp | -52.96% |
AIM ImmunoTech Inc | -19.40% |
IGC Pharma Inc | 69.70% |
NovaBay Pharmaceuticals Inc | -83.53% |
Protalix BioTherapeutics Inc | -51.69% |